Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆

Paolo G. Casali, Axel Le Cesne, A. Poveda Velasco, Dusan Kotasek, Piotr Rutkowski, P. Hohenberger, Elena Fumagalli, Ian Judson, Antoîne Italiano, Hans Gelderblom, Nicolas Penel, J.T. Hartmann, Florence Duffaud, David Goldstein, Javier Martín‐Broto, Alessandro Gronchi, Eva Wardelmann, Sandrine Marréaud, John Zalcberg, Saskia Litière, Jean‐Yves Blay